The Innovative Molecular Analysis Technologies (IMAT) program was established to support the development, technical maturation, and dissemination of novel and potentially transformative next-generation technologies through an approach of balanced but targeted innovation. In support of its mission, the IMAT program utilizes a variety of investigator-initiated research project grant mechanisms while retaining a strong commitment to diversity and to the training of scientists and clinicians in cross-cutting, research-enabling disciplines.
The NCI is very pleased to announce that the IMAT program has approved reissuance for funding opportunity announcements through calendar year (CY) 2015.
Please use the links below for examples of past funding opportunities. New funding opportunities will be linked once posted.
Funding opportunities in technology development are intended to support the inception, maturation, and subsequent dissemination of technically innovative and potentially transformative emerging technologies. These opportunities exist in parallel with various educational and training programs aimed at the recruitment, retention, and promotion of a diverse pool of talent in areas of emerging technology.
NIH seeks guidance from the community on supporting technology development more effectively. Please consider responding before Aug. 7, 2015 to an open Request for Information (RFI) with suggestions for how to best review, support and evaluate programs that support development of biomedical technology by following this link.
Next FY15 IMAT application due date is set for Sept. 22, 2015. See Funding Opportunities for more information.
New funding (sub-contract) opportunity
Biospecimen Core Resource (BCR), capable of receiving, qualifying, processing, and distributing annotated biospecimens as part of the NCI's Clinical Proteomic Tumor Analysis Consortium (CPTAC). To learn more, please click here.
MRS Fall 2015 announced
MRS Fall 2015 announced (11/29/2015 – 12/4/2015, Boston, MA), with a symposium track (K) on materials science, technology and devices for cancer diagnosis and treatment. more+
Funding opportunity for Innovative Research in Cancer Nanotechnology
The NCI has a funding opportunity for Innovative Research in Cancer Nanotechnology (IRCN). more+
Best Practices in Cell Culture Workshop
The NCI is holding a workshop for “Best Practices in Cell Culture” at the ATCC in Manassas, VA on July 21-24, 2015. more+
Coming Soon! 16th Annual PI Meeting – November 12-13, 2015, Porter Center, NIH Campus, Bethesda MD (Registration will open in late August/early September)
The yearly meetings for the Principal Investigators funded through the IMAT programs are held to provide a forum to discuss progress; forge collaborations between investigators; showcase complementary programs and resources; and solicit feedback from investigators. Funded PIs are asked to save the date. Supported investigators with questions about this meeting are encouraged to contact Tony Dickherber at email@example.com.
The Innovative Molecular Analysis Technologies Development for Cancer Research and Clinical Care (IMAT-SBIR, PAR-13-327) funding opportunity provides to small businesses conducting research towards the commercial development of emerging molecular and/or cellular analytical technologies intended for cancer detection and/or characterization. more +
TGen and Ceres Nanosciences announce collaboration to develop high-throughput Nanotrap enrichment methods for Mass Spectrometry (June 2014) more +
IMAT support leads to new commercial glycan tagging kit from Cambridge Isotope Laboratories.
Congratulations to the Muddiman group (NCSU) for commercial launch of their INLIGHTTM glycan tagging kit, an important new tool for enabling mass spectrometry-based glycomics research. more +